September 23, 2011 — Hologic Inc. announced that Rob Cascella, company president and CEO, will preside over the NASDAQ stock market opening bell ceremony marking the start of Breast Cancer Awareness Month. The ceremony will begin at 9:15 a.m. (ET) on Oct. 3, 2011.

Breast cancer statistics reveal that:

  • One in eight women in the United States will get breast cancer in their lifetime
  • Breast cancer is the second leading cause of cancer death in the U.S. It is the leading cause of death in women age 35 to 65.
  • Between 1990 and 2007, the mortality rate from breast cancer in the United States decreased by 31 percent, principally due to the contribution of mammographic screening and improved therapies.
  • Approximately 2.5 million women with a history of breast cancer living in America are alive today.

In February 2011, Hologic was the first company to obtain U.S. Food and Drug Administration (FDA) approval for 3-D breast tomosynthesis.

In clinical studies, radiologists reading 2-D mammography and 3-D breast tomosynthesis images - compared to 2-D images alone - demonstrated superior clinical performance in specificity. The combined viewing also illustrated the confidence to rule out breast cancer without recalling the patient for further study and improved sensitivity.

In addition to mammography screening, Hologic provides products and technologies to address the entire continuum of screening, definitive diagnosis and therapy. If a suspicious lesion is detected, breast biopsy systems are designed to provide clinicians with easy access with fewer needle insertions.

Should cancer be detected in its early stages, many women are candidates for targeted radiation therapy, a patient-friendly and effective alternative for women that qualify. Hologic's breast magnetic resonance imaging (MRI) solutions are highly sensitive for cancer staging, problem solving, post-treatment surveillance, and other indications. Breast MRI can detect many breast cancers that are often hidden when using standard imaging.

In addition, for every woman making the Promise to Me pledge, Hologic will contribute funds for mammograms and cervical cancer and bone density screening for women that cannot afford the exams.

The NASDAQ stock market opening bell ceremony will be aired live on NASDAQ.com.

For more information: www.hologic.com


Related Content

News | Breast Imaging

April 1, 2026 — QT Imaging Holdings has released its latest image reconstruction software update, version 4.5.0. This ...

Time April 02, 2026
arrow
News | Ultrasound Imaging

March 30, 2026 — Butterfly Network, Inc. has received clearance from the U.S. Food and Drug Administration (FDA) for a ...

Time April 01, 2026
arrow
News | Breast Imaging

March 30, 2026 — Each year, the Alumni Association at the University of Missouri-Kansas City, recognizes the ...

Time March 31, 2026
arrow
News | MRI Breast | Breast cancer, dense breast, MRI

March 2, 2026 — A collaborative modeling study found that adding biennial breast magnetic resonance imaging (MRI) to ...

Time March 20, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
Subscribe Now